Pulmonary Capillary Hemangiomatosis and Pulmonary Veno-occlusive Disease

Clin Chest Med. 2016 Sep;37(3):523-34. doi: 10.1016/j.ccm.2016.04.014. Epub 2016 Jun 30.

Abstract

This article provides an overview of pulmonary veno-occlusive disease (PVOD) and pulmonary capillary hemangiomatosis (PCH), two disorders that challenge clinicians, radiologists, and pathologists because they often mimic pulmonary arterial hypertension (PAH). The article reviews the features that differentiate PVOD and PCH from PAH. The article also describes the overlap of PVOD and PCH, highlighted by recent reports of families diagnosed with PVOD or PCH caused by EIF2AK4 mutations. In addition, the article outlines current approaches to the diagnosis and treatment of PVOD and PCH.

Keywords: Genetics; Pulmonary capillary hemangiomatosis; Pulmonary disorder; Pulmonary hypertension; Pulmonary veno-occlusive disease.

Publication types

  • Review

MeSH terms

  • Diagnosis, Differential
  • Hemangioma, Capillary / diagnosis*
  • Hemangioma, Capillary / genetics
  • Hemangioma, Capillary / pathology
  • Hemangioma, Capillary / physiopathology
  • Humans
  • Hypertension, Pulmonary / diagnosis*
  • Hypertension, Pulmonary / physiopathology
  • Lung Neoplasms / diagnosis*
  • Lung Neoplasms / genetics
  • Lung Neoplasms / pathology
  • Lung Neoplasms / physiopathology
  • Mutation
  • Neoplasms, Multiple Primary / diagnosis*
  • Neoplasms, Multiple Primary / genetics
  • Neoplasms, Multiple Primary / pathology
  • Neoplasms, Multiple Primary / physiopathology
  • Protein Serine-Threonine Kinases / genetics
  • Pulmonary Veno-Occlusive Disease / diagnosis*
  • Pulmonary Veno-Occlusive Disease / genetics
  • Pulmonary Veno-Occlusive Disease / pathology
  • Pulmonary Veno-Occlusive Disease / physiopathology

Substances

  • EIF2AK4 protein, human
  • Protein Serine-Threonine Kinases